We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 865

The European Patent Office implements changes regarding lack of unity in national phase applications

  • Nutter McClennen & Fish LLP
  • -
  • European Union
  • -
  • September 19 2014

On November 1, 2014, the European Patent Office (EPO) will implement a revision to Rule 164 EPC that allows Patent Cooperation Treaty (PCT

The Court of Milan in Sanofi v. Teva “repeats” the CJEU judgment in Actavis

  • Martini Manna
  • -
  • European Union, Italy
  • -
  • September 18 2014

By judgment No. 985514 published on 1 August, the Business Chamber “A” of the Court of Milan has decided the lawsuit filed by Sanofi against Teva

Unified Patent Court Preparatory Committee publishes updated roadmap

  • D Young & Co
  • -
  • European Union
  • -
  • September 17 2014

The Preparatory Committee of the Unified Patent Court (UPC) published a revised roadmap on 16 September 2014. This provides an update on progress

Victory in European VYVANSE patent challenge

  • Frommer Lawrence & Haug LLP
  • -
  • European Union, USA
  • -
  • September 15 2014

At the conclusion of oral opposition proceedings on September 11, 2014, the European Patent Office ("EPO") maintained Shire's European patent

Update on the European Unitary Patent

  • Watermark Patent & Trade Marks Attorneys
  • -
  • European Union
  • -
  • September 15 2014

The European Unitary Patent (UP) is unlikely to come into force until late 2015 or early 2016, as some hurdles remain to be cleared, including how to

Advocate General: the use of unfertilised human ova is patentable

  • De Brauw Blackstone Westbroek
  • -
  • European Union, Netherlands
  • -
  • September 10 2014

In International Stem Cell Corporation, the Advocate General of the European Court of Justice recently opined that parthenogenetically activated

The new proposals for patent law may increase clinical trials conduct

  • Eversheds LLP
  • -
  • European Union, United Kingdom
  • -
  • August 21 2014

The Legislative Reform (Patents) Order 2014 (the "Order") is scheduled to come into force on 1 October 2014 (this may change during Parliamentary

Stem cell patentability: European update following opinion of Advocate-General in ISCC and the Australian position

  • Freehills Patent Attorneys
  • -
  • Australia, European Union
  • -
  • August 18 2014

The recent Opinion of the Advocate-General suggests that a clarification and moderation of the Court of Justice of the European Union's (CJEU

Canadian patent term extension draft treaty

  • Bereskin & Parr LLP
  • -
  • Canada, European Union
  • -
  • August 15 2014

Canada and Europe announced in October 2013, an agreement in principle on a Comprehensive Economic and Trade Agreement ("CETA"). Its most significant

Stem cell patentability: European update following opinion of Advocate-General in ISCC and the Australian position

  • Herbert Smith Freehills LLP
  • -
  • Australia, European Union
  • -
  • August 14 2014

A recent Opinion of the Advocate-General of the Court of Justice of the European Union (CJEU) suggests that a clarification and moderation of the